Incidence and survival of interstitial lung diseases in the UK in 2010–2019
Background With the introduction of the antifibrotic drugs targeting progressive pulmonary fibroses, it becomes imperative to provide reliable contemporary estimates of the most common interstitial lung diseases. We aimed to provide contemporary estimates of the incidence and survival of idiopathic...
Saved in:
| Main Authors: | Francesca Gonnelli, Neva Eleangovan, Ursie Smith, Heath Heatley, Vidya Navarantam, Tamera J. Corte, David B. Price, Victoria Carter, Martina Bonifazi, Caitlin C. Fermoyle, Richard Hubbard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2025-03-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/11/2/00823-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatable traits in interstitial lung disease: a narrative review
by: Megan Harrison, et al.
Published: (2025-05-01) -
Association of Frequent Short-Acting Beta-Agonist Inhaler Prescriptions with Acute Cardiovascular Events
by: Pfeffer PE, et al.
Published: (2025-07-01) -
Myeloperoxidase‐Antibody Positivity and Progression to Microscopic Polyangiitis in Interstitial Lung Disease: A Case Series
by: Michael Hoskins, et al.
Published: (2025-07-01) -
The interstitial lung disease patient pathway: from referral to diagnosis
by: Graham Lough, et al.
Published: (2025-03-01) -
Brexit and UK Environmental Policy and Politics
by: Charlotte Burns, et al.
Published: (2018-12-01)